Prelude Therapeutics Incorporated (PRLD) Deep Dive Video

Summary

PRLD is a selectivity-led oncology bet where 2027 human data—and Incyte’s option decision—can turn a focused two-asset pipeline into a royalty machine or a dilution spiral.

View PRLD stock page · Read the PRLD research report

Loading the video player…